These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8227566)

  • 1. Interobserver variability in CT and MR staging of lung cancer.
    Webb WR; Sarin M; Zerhouni EA; Heelan RT; Glazer GM; Gatsonis C
    J Comput Assist Tomogr; 1993; 17(6):841-6. PubMed ID: 8227566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma.
    Manfredi R; Pirronti T; Bonomo L; Marano P
    MAGMA; 1996; 4(3-4):257-62. PubMed ID: 9220416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT.
    Cascade PN; Gross BH; Kazerooni EA; Quint LE; Francis IR; Strawderman M; Korobkin M
    AJR Am J Roentgenol; 1998 Apr; 170(4):927-31. PubMed ID: 9530036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
    Webb WR; Gatsonis C; Zerhouni EA; Heelan RT; Glazer GM; Francis IR; McNeil BJ
    Radiology; 1991 Mar; 178(3):705-13. PubMed ID: 1847239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Staging of non-small cell bronchial carcinoma using CT and MRT].
    Layer G; van Kaick G
    Radiologe; 1990 Apr; 30(4):155-63. PubMed ID: 2160670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma.
    Hofman MS; Smeeton NC; Rankin SC; Nunan T; O'Doherty MJ
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):194-9. PubMed ID: 18828012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathoracic lymph node evaluation by CT and MRI with histopathologic correlation in non-small cell bronchogenic carcinoma.
    Georgian D; Rice TW; Mehta AC; Wiedemann HP; Stoller JK; O'Donovan PB
    Clin Imaging; 1990 Mar; 14(1):35-40. PubMed ID: 2157544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA.
    Crisci R; Di Cesare E; Lupattelli L; Coloni GF
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):214-7. PubMed ID: 9080145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging bronchogenic carcinoma.
    Patz EF
    Chest; 2000 Apr; 117(4 Suppl 1):90S-95S. PubMed ID: 10777461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Staging of bronchogenic cancer. Determination of mediastinal lymphatic involvement using magnetic resonance].
    Crisci R; Pavone P; Giuliani S; Di Egidio M; Vecchio L; Passariello R; Coloni GF
    Minerva Chir; 1990 Feb; 45(3-4):147-52. PubMed ID: 2356028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MRI of bronchogenic carcinoma].
    Bittner RC; Nakamura T; Schörner W; Weiss T; Felix R
    Rinsho Hoshasen; 1989 Jan; 34(1):37-43. PubMed ID: 2724606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
    Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MRI for the staging of bronchogenic carcinoma: comparison with CT and histopathologic staging--preliminary results.
    Stiglbauer R; Schurawitzki H; Klepetko W; Kramer J; Schratter M; Tscholakoff D; Eckersberger F
    Clin Radiol; 1991 Nov; 44(5):293-8. PubMed ID: 1760903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT.
    Huellner MW; de Galiza Barbosa F; Husmann L; Pietsch CM; Mader CE; Burger IA; Stolzmann P; Delso G; Frauenfelder T; von Schulthess GK; Veit-Haibach P
    J Nucl Med; 2016 Jan; 57(1):21-6. PubMed ID: 26471696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Computer tomography and staging of bronchogenic carcinoma. Prospective study].
    Stolz AJ; Pipková R; Schützner J; Simonek J; Lischke R; Pafko P
    Cas Lek Cesk; 2004; 143(11):752-4; discussion 754-5. PubMed ID: 15628570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma.
    Gdeedo A; Van Schil P; Corthouts B; Van Mieghem F; Van Meerbeeck J; Van Marck E
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):224-7. PubMed ID: 9288511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging strategies in the staging of lung cancer.
    Webb WR; Golden JA
    Clin Chest Med; 1991 Mar; 12(1):133-50. PubMed ID: 2009741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of computed tomography to the staging of non-small-cell primary bronchogenic carcinoma: a prospective study.
    Wouters EF; Oei TK; Soeters PB; Havenith MG; Van Engelshoven JM; Greve LH
    Neth J Surg; 1986 Dec; 38(6):167-70. PubMed ID: 3027619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.